Drug profile · INN
triamcinolone + neomycin + gramicidin + nystatin
OTOCOMB OTIC
triamcinolone + neomycin + gramicidin + nystatin (OTOCOMB OTIC) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — triamcinolone + neomycin + gramicidin + nystatin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
triamcinolone + neomycin + gramicidin + nystatin (OTOCOMB OTIC) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN triamcinolone + neomycin + gramicidin + nystatin
Brand OTOCOMB OTIC
Originator Lacuna Pharma Pty Ltd
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is triamcinolone + neomycin + gramicidin + nystatin?
triamcinolone + neomycin + gramicidin + nystatin (OTOCOMB OTIC) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for triamcinolone + neomycin + gramicidin + nystatin?
OTOCOMB OTIC is a marketed brand name for triamcinolone + neomycin + gramicidin + nystatin. Check FDA Drugs@FDA for the current US label holder and prescribing information.